Document Classification

Section Type: METHODS

Text: One hundred and ten patients with CHD and its equivalents with serum total cholesterol (TC) > or = 3. 5 mmol/L were randomly assigned into three treatment groups : (1) atorvastatin group (n = 38), receiving atorvastatin 10 mg/d for 8 weeks ; (2) niacin ER group (n = 38), given niacin ER 500 mg/d for 4 weeks and then 1000 mg/d for 4 weeks ; (3) combination treatment group (n = 34), treated with atorvastatin (10 mg/d) plus niacin ER, with the dose initiating from 500 mg/d, and increasing to 1000 mg/d after 4 weeks, for 8 weeks.